Released
October 9, 2025
Expires
October 9, 2026
Media Type
Internet
Completion Time
60 minutes
Specialties
Allergy & Immunology, Dermatology, Pediatrics, Primary Care
Topics
Pediatrics, Atopic Dermatitis
CME Info
This activity is jointly provided by Global Education Group and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC), in collaboration with Asthma and Allergy Foundation of America (AAFA).
ACKNOWLEDGEMENT
This activity is supported by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals.
DATE OF RELEASE/EXPIRATION
This activity was released on October 9, 2025, and is valid until October 9, 2026. Requests for credit must be made no later than October 9, 2026.
Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credits™
Target Audience
The educational design of this activity addresses the needs of adult and pediatric dermatology and allergy/immunology clinicians, pediatricians, PCPs/family medicine clinicians.
Program Overview
Studies have shown that patients with moderate-to-severe atopic dermatitis (AD) are at an increased risk for developing several types of comorbidities, including atopic diseases associated with type 2 (T2) inflammation, autoimmune diseases, and psychiatric conditions such as anxiety and depression. In this on-demand educational session, a panel of three expert dermatologists will discuss the risks of AD patients developing comorbid conditions as a result of their disease, the tools available to screen and monitor patients for these conditions, and how to incorporate this knowledge into developing informed, comprehensive treatment and referral plans to determine the best outcomes for AD patients.
Learning Objectives
After completing this activity, the participant should be better able to:
- Explain the underlying T2 pathophysiology of the atopic march that place people with moderate-to-severe AD at high risk of developing other atopic diseases
- Review comorbid autoimmune conditions for which moderate-to-severe AD patients are at risk and their impacts on AD management
- Summarize the psychosocial impact of moderate-to-severe AD on patients’ mental health and quality of life
- Describe informed, multidisciplinary care strategies to improve overall treatment and quality of life for patients with moderate-to-severe AD
Faculty
Brad P. Glick, DO, MPH, FAAD
Chair and Dermatology Residency Director
Larkin Health System
Miami, FL
Adelaide A. Hebert, MD
Professor of Dermatology and Pediatrics
The University of Texas Medical School
Houston, TX
Jonathan Silverberg, MD, PHD, MPH
Professor
George Washington University
School of Medicine and Health Sciences
Washington, DC
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC). Global is accredited by the ACCME to provide continuing medical education for physicians.
PHYSICIAN CREDIT DESIGNATION
Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ESTIMATED TIME TO COMPLETE
This activity should take approximately 60 minutes to complete.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a score of 70% on the post-test.
Hardware/Software Requirements
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosures of Relevant Financial Relationships
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
The planners and managers at Global Education Group and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC) have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC) do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Medlive Privacy Policy
Contact Information
Accreditation Support:
For information about the accreditation of this program, please contact Global at 303-395-1782 or [email protected].
Technical Support:
For any technical issues or issues with your CME Certificate, please contact Medlive at 877-394-1306 or at [email protected].